COPS5 and diffuse large B-cell lymphoma: The fact that doxycycline inhibited CSN5 activity significantly in vitro only at relatively high drug concentrations (IC50: ~110 μM) thus raised the question whether the concentrations of doxycycline in the DLBCL cells under our experimental conditions were sufficient to inhibit CSN5 activity.